Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?news2021-11-29T19:40:28+00:00November 29th, 2021|The New York Times|
Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out.news2021-11-28T23:55:10+00:00November 28th, 2021|The New York Times|
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drugnews2021-11-22T16:00:09+00:00November 22nd, 2021|The New York Times|
Opioid Makers Win Major Victory in California Trialnews2021-11-02T16:51:06+00:00November 2nd, 2021|The New York Times|
Why Aren’t More People Comparison Shopping for Health Plans?news2021-10-30T09:00:21+00:00October 30th, 2021|The New York Times|
How the Delta Variant is Pushing Americans to Get Vaccinatednews2021-09-28T19:24:33+00:00September 28th, 2021|The New York Times|
Specialty Pharmacies Cater to the Blind and Those With Impaired Visionnews2021-09-21T16:28:23+00:00September 21st, 2021|The New York Times|
The Pain Wouldn’t Stop — Because Her Medication Had Been Stolennews2021-09-17T19:01:30+00:00September 17th, 2021|The New York Times|
Study of Covid Booster Shot Benefits Fans Debate Over Extra Dosesnews2021-09-15T21:19:57+00:00September 15th, 2021|The New York Times|
House Committees Demand F.D.A. Records on Alzheimer’s Drug Approvalnews2021-09-02T17:20:46+00:00September 2nd, 2021|The New York Times|
